13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001697013
Total reported value
$1.9B
$1.9B
70 檔
33.5%
As reported in its official Q1 2024 Form 13F filing, Eversept Partners, LP's tracked investment portfolio stood at $1.9B with 70 total positions.
In Q1 2024, Eversept Partners, LP displayed an active expansion posture, initiating 16 new positions and adding to 13 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 10.85% | -1.58% | -21.03% | |
| 2 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 10.79% | -3.89% | +26.88% | |
| 3 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 9.68% | -3.49% | +117.87% | |
| 4 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 6.03% | — | +19.82% | |
| 5 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.67% | — | -2.10% | |
| 6 | VERA | Vera Therapeutics Inc | Stock-Other | 5.25% | +0.32% | -4.75% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 4.97% | -0.38% | -7.39% | |
| 8 | UTHR | United Therapeutics CORP | Stock-Healthcare | 3.85% | -0.17% | +1.99% | |
| 9 | RVTY | Revvity Inc | Stock-Healthcare | 3.38% | +0.09% | +163.94% | |
| 10 | TECH | Bio-techne CORP | Stock-Healthcare | 2.85% | -0.28% | +30.60% | |
| 11 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.31% | +0.01% | -9.57% | |
| 12 | HQY | Healthequity Inc | Stock-Healthcare | 2.29% | -0.23% | EXIT | |
| 13 | PFE | Pfizer Inc | Stock-Healthcare | 2.04% | — | — | |
| 14 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.99% | +0.46% | -5.70% | |
| 15 | CYH | Community Health Systems Inc | Stock-Other | 1.86% | +0.01% | +10.37% | |
| 16 | SWAVUSD | Shockwave Medical Inc | Stock-Other | 1.75% | — | +6.24% | |
| 17 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.43% | — | -36.48% | |
| 18 | THC | Tenet Healthcare CORP | Stock-Healthcare | 1.23% | +0.82% | -6.21% | |
| 19 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 1.09% | +0.23% | +15.95% | |
| 20 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 1.06% | -3.67% | EXIT | |
| 21 | VTRS | Viatris Inc | Stock-Healthcare | 1.05% | — | — | |
| 22 | PCVX | Vaxcyte Inc | Stock-Other | 0.90% | -0.93% | -15.61% | |
| 23 | HUM | Humana Inc | Stock-Healthcare | 0.82% | +0.64% | NEW | |
| 24 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.79% | +0.37% | NEW | |
| 25 | ✓ | Taro Pharmaceutical Inds LTD | Stock-Other | 0.74% | — | +2.95% | |
| 26 | MNKD | Mannkind CORP | Stock-Other | 0.72% | — | — | |
| 27 | DHR | Danaher CORP | Stock-Healthcare | 0.68% | — | -0.45% | |
| 28 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.67% | +0.33% | — | |
| 29 | ZIMV | Zimvie Inc | Stock-Other | 0.62% | — | +3.30% | |
| 30 | GH | Guardant Health Inc | Stock-Healthcare | 0.62% | — | — | |
| 31 | BKD | Brookdale Senior Living Inc | Stock-Other | 0.58% | +0.27% | — | |
| 32 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.56% | — | -5.46% | |
| 33 | IMVT | Immunovant Inc | Stock-Other | 0.55% | — | +124.55% | |
| 34 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.53% | +0.42% | NEW | |
| 35 | KPTIEUR | Karyopharm Therapeutics Inc | Stock-Other | 0.51% | — | — | |
| 36 | PBYI | Puma Biotechnology Inc | Stock-Other | 0.50% | — | -15.84% | |
| 37 | ELV | Elevance Health Inc | Stock-Healthcare | 0.50% | — | -4.64% | |
| 38 | TVTX | Travere Therapeutics Inc | Stock-Other | 0.49% | +1.50% | — | |
| 39 | CNC | Centene CORP | Stock-Healthcare | 0.49% | -0.19% | EXIT | |
| 40 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 0.49% | -0.56% | -6.32% | |
| 41 | GOSS | Gossamer Bio Inc | Stock-Other | 0.47% | — | -6.81% | |
| 42 | TSHA | Taysha Gene Therapies Inc | Stock-Other | 0.45% | — | -38.49% | |
| 43 | TSVT* | 2seventy Bio Inc | Stock-Other | 0.42% | — | +3.39% | |
| 44 | STRO | Sutro Biopharma, Inc. | Stock-Other | 0.41% | — | +3.31% | |
| 45 | LQDA | Liquidia CORP | Stock-Other | 0.39% | +0.42% | -42.49% | |
| 46 | NVROEUR | Nevro CORP | Stock-Other | 0.38% | — | — | |
| 47 | ✓ | Amarin Corp PLC | Stock-Other | 0.37% | — | +1.92% | |
| 48 | ✓ | Merus N V | Stock-Other | 0.36% | — | +3.25% | |
| 49 | ICLR | ICON Public Limited Company | Stock-Healthcare | 0.34% | -0.40% | EXIT | |
| 50 | WAT | Waters CORP | Stock-Healthcare | 0.31% | — | -50.84% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QQQ | Invesco Qqq Trust Series 1 | +4.3% | +117.87% | Add |
| 2 | VERA | Vera Therapeutics Inc | +2.7% | -4.75% | Trim |
| 3 | PFE | Pfizer Inc | +2% | NEW | New buy |
| 4 | RVTY | Revvity Inc | +1.6% | +163.94% | Add |
| 5 | GSK | Gsk Plc-spon Adr | +1.1% | +26.88% | Add |
| 6 | VTRS | Viatris Inc | +1.1% | NEW | New buy |
| 7 | HUM | Humana Inc | +0.7% | +1756.43% | Add |
| 8 | MNKD | Mannkind CORP | +0.7% | NEW | New buy |
| 9 | LLY | Eli Lilly & Co | +0.7% | NEW | New buy |
| 10 | GH | Guardant Health Inc | +0.6% | NEW | New buy |
| 11 | BKD | Brookdale Senior Living Inc | +0.6% | NEW | New buy |
| 12 | NVO | Novo-nordisk A/s-spons Adr | +0.5% | NEW | New buy |
| 13 | KPTIEUR | Karyopharm Therapeutics Inc | +0.5% | NEW | New buy |
| 14 | TVTX | Travere Therapeutics Inc | +0.5% | NEW | New buy |
| 15 | SWAVUSD | Shockwave Medical Inc | +0.5% | +6.24% | Add |
| 16 | NVROEUR | Nevro CORP | +0.4% | NEW | New buy |
| 17 | STOK | Stoke Therapeutics Inc | +0.3% | NEW | New buy |
| 18 | CRBP | Corbus Pharmaceuticals Holdi | +0.2% | NEW | New buy |
| 19 | ALEC | Alector Inc | +0.2% | NEW | New buy |
| 20 | MOR2 | Morphosys AG Adr | +0.2% | NEW | New buy |
| 21 | NAMS | NewAmsterdam Pharma Company N.V. | +0.2% | -5.46% | Trim |
| 22 | IMVT | Immunovant Inc | +0.1% | +124.55% | Add |
| 23 | VKTX | Viking Therapeutics Inc | +0.1% | NEW | New buy |
| 24 | 430 | Terns Pharmaceuticals Inc | +0.1% | NEW | New buy |
| 25 | ✓ | Merus N V | +0.1% | +3.25% | Add |
| 26 | TEVA | Teva Pharmaceutical-sp Adr | 0% | -2.10% | Trim |
| 27 | STRO | Sutro Biopharma, Inc. | 0% | +3.31% | Add |
| 28 | THC | Tenet Healthcare CORP | 0% | -6.21% | Trim |
| 29 | TSVT* | 2seventy Bio Inc | 0% | +3.39% | Add |
| 30 | GOSS | Gossamer Bio Inc | -0.1% | -6.81% | Trim |
| 31 | CYH | Community Health Systems Inc | -0.1% | +10.37% | Add |
| 32 | MCRB1EUR | Seres Therapeutics Inc | -0.2% | -20.79% | Trim |
| 33 | INSP | Inspire Medical Systems Inc | -0.3% | +19.82% | Add |
| 34 | BHVN | Biohaven Ltd. | -0.3% | EXIT | Sold out |
| 35 | TECH | Bio-techne CORP | -0.3% | +30.60% | Add |
| 36 | BCRX | Biocryst Pharmaceuticals Inc | -0.3% | -6.32% | Trim |
| 37 | LQDA | Liquidia CORP | -0.3% | -42.49% | Trim |
| 38 | PCVX | Vaxcyte Inc | -0.4% | -15.61% | Trim |
| 39 | HCA | Hca Healthcare Inc | -0.4% | -9.57% | Trim |
| 40 | A | Agilent Technologies Inc | -0.5% | EXIT | Sold out |
| 41 | WAT | Waters CORP | -0.5% | -50.84% | Trim |
| 42 | HQY | Healthequity Inc | -0.6% | -14.87% | Trim |
| 43 | KRYS | Krystal Biotech Inc | -0.7% | -77.03% | Trim |
| 44 | UTHR | United Therapeutics CORP | -0.9% | +1.99% | Add |
| 45 | ILMN | Illumina Inc | -1.1% | EXIT | Sold out |
| 46 | ARGX | Argenx Se - Adr | -1.4% | -36.48% | Trim |
| 47 | SNDX | Syndax Pharmaceuticals Inc | -1.5% | -7.39% | Trim |
| 48 | NTRA | Natera Inc | -1.5% | -21.03% | Trim |
| 49 | IMGNEUR | Immunogen Inc | -2% | EXIT | Sold out |
| 50 | SPY | Ss Spdr S&p 500 ETF Trust-us | -4% | -74.75% | Trim |
According to official SEC Form 13F filings, Eversept Partners, LP reported a total U.S. public equity portfolio value of $1.9B across 70 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, GSK, QQQ) accounted for 33.5% of total reported equity market value during Q1 2024.
Top New Position Initiated
PFE
市值: $30.6M
Top Position Liquidated / Trimmed
IMGNEUR
前期市值: $22.2M
During Q1 2024, Eversept Partners, LP's top holdings by market value included NTRA (10.8%)、GSK (10.8%)、QQQ (9.7%). The largest single position, NTRA, represented 10.8% of total portfolio value.
In Q1 2024, Eversept Partners, LP made 50 total portfolio adjustments, initiating 16 new buys, adding to 13 positions, trimming 17 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.